Stay updated on Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page.

Latest updates to the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page
- Check7 days agoChange DetectedMelanoma and related topics (MedlinePlus Genetics) were removed from the related topics section. The main study details and sections remain unchanged.SummaryDifference0.2%

- Check14 days agoChange DetectedThe page adds Melanoma and related topics including MedlinePlus Genetics, and updates the revision to v3.4.2. The funding-lapse notice and the older revision note v3.4.1 are removed.SummaryDifference0.6%

- Check21 days agoChange DetectedAdded a government funding lapse notice banner with status guidance and updated the site revision to v3.4.1. Removed Melanoma-related topics and MedlinePlus Genetics, and updated the page revision reference to v3.4.0.SummaryDifference0.6%

- Check28 days agoChange DetectedAdded a Show glossary option and made minor text/label adjustments (e.g., capitalization of QC criteria labels and a new revision tag v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe only change is a revision label update from v3.3.3 to v3.3.4, a minor metadata update with no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Melanoma and related topic links (MedlinePlus Genetics) and a consolidated Locations section including California, New Jersey, New York, and Pennsylvania. Removed the separate state location subsections (California Locations, New Jersey Locations, New York Locations, Pennsylvania Locations) and updated the page revision to v3.3.3.SummaryDifference0.7%

Stay in the know with updates to Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page.